ATE233557T1 - Verwendung von konjugiertes linolensäure zur steigerung der aktivität von natural killer- lymphozyten - Google Patents

Verwendung von konjugiertes linolensäure zur steigerung der aktivität von natural killer- lymphozyten

Info

Publication number
ATE233557T1
ATE233557T1 AT97945605T AT97945605T ATE233557T1 AT E233557 T1 ATE233557 T1 AT E233557T1 AT 97945605 T AT97945605 T AT 97945605T AT 97945605 T AT97945605 T AT 97945605T AT E233557 T1 ATE233557 T1 AT E233557T1
Authority
AT
Austria
Prior art keywords
activity
natural killer
increase
killer lymphocytes
linolenic acid
Prior art date
Application number
AT97945605T
Other languages
English (en)
Inventor
Mark E Cook
Sohee Kim
Michael W Pariza
Danielle Devoney
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Application granted granted Critical
Publication of ATE233557T1 publication Critical patent/ATE233557T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
AT97945605T 1996-11-05 1997-11-04 Verwendung von konjugiertes linolensäure zur steigerung der aktivität von natural killer- lymphozyten ATE233557T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3039496P 1996-11-05 1996-11-05
PCT/US1997/020098 WO1998019675A1 (en) 1996-11-05 1997-11-04 Use of conjugated linoleic acid to enhance natural killer lymphocyte function

Publications (1)

Publication Number Publication Date
ATE233557T1 true ATE233557T1 (de) 2003-03-15

Family

ID=21854010

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97945605T ATE233557T1 (de) 1996-11-05 1997-11-04 Verwendung von konjugiertes linolensäure zur steigerung der aktivität von natural killer- lymphozyten

Country Status (8)

Country Link
US (1) US5914346A (de)
EP (1) EP0941088B1 (de)
JP (1) JP2001503430A (de)
AT (1) ATE233557T1 (de)
AU (1) AU5104198A (de)
CA (1) CA2267109C (de)
DE (1) DE69719539D1 (de)
WO (1) WO1998019675A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776353B1 (en) * 1998-03-17 2010-08-17 Aker Biomarine Asa Conjugated linoleic acid compositions
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
EP1231913A2 (de) * 1999-07-09 2002-08-21 Pharmacia Corporation Behandlung von cyclooxygenase-2 bedingten erkrankungen unter verwendung von conjugierten fettsäureverbindungen
US6077868A (en) * 1999-07-20 2000-06-20 Wisconsin Alumni Research Foundation Selective inhibition of cyclooxygenase-2
CA2404799C (en) * 2000-04-06 2007-08-07 Conlinco, Inc. Conjugated linoleic acid compositions
JP4786030B2 (ja) * 2000-12-27 2011-10-05 森永乳業株式会社 ナチュラルキラー細胞活性化剤
US6395782B1 (en) 2001-03-02 2002-05-28 Wisconsin Alumni Research Foundation Method of increasing longevity and preventing body weight wasting in autoimmune disease by using conjugated linoleic acid
US6479683B1 (en) 2001-03-06 2002-11-12 Ag Processing Inc Process for conjugating fatty acid esters
US7098352B2 (en) * 2001-11-16 2006-08-29 Virtus Nutrition Llc Calcium salt saponification of polyunsaturated oils
CA2396840A1 (en) * 2002-08-06 2004-02-06 Juan Miguel Garro Galvez New conjugated linolenic acids and methods for commercial preparation, purification and uses
CA2436650A1 (en) * 2003-08-06 2005-02-06 Naturia Inc. Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
WO2005063230A1 (en) * 2003-12-30 2005-07-14 Universite Laval Use of conjugated linolenic acids for reducing body fat mass
JP2005194222A (ja) * 2004-01-06 2005-07-21 Otsuka Pharmaceut Factory Inc サイトカイン誘発剤
US20050154059A1 (en) * 2004-01-13 2005-07-14 Cook Mark E. Method of treating type III hypersensitive reaction-related diseases and conditions by using conjugated linoleic acid
EA200602014A1 (ru) * 2004-04-30 2007-08-31 ВИРТУС НЬЮТРИШН ЭлЭлСи Синтез солей одновалентных и двухвалентных металлов полиненасыщенных жирных кислот
EP1597978A1 (de) 2004-05-17 2005-11-23 Nutricia N.V. Synergie von GOS und polyfruktose
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
CN101658678A (zh) * 2004-09-15 2010-03-03 森永乳业株式会社 筛选具有自然杀伤细胞增殖作用的物质和增殖自然杀伤细胞的方法
KR101148901B1 (ko) 2004-09-29 2012-05-29 모리나가 뉴교 가부시키가이샤 고혈당 개선용 음식품
PT1835021E (pt) * 2004-12-28 2011-04-29 Meiji Seika Kaisha Nova estirpe que confere a um hospedeiro propriedades anti-doença e composição de células bacterianas

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4282265A (en) * 1980-01-14 1981-08-04 Bristol-Myers Company Fat compositions for infant formulas
IE54795B1 (en) * 1982-04-29 1990-02-14 Efamol Ltd Pharmaceutical composition
US4603142A (en) * 1984-06-01 1986-07-29 Wisconsin Alumni Research Foundation Cholesterol lowering method of use
JPS61216658A (ja) * 1985-03-20 1986-09-26 Agency Of Ind Science & Technol 生理活性物質を含有する卵、肉、および乳
JPS6398355A (ja) * 1986-10-16 1988-04-28 Kazumitsu Maruta 動物用飼料
US5017614A (en) * 1989-02-17 1991-05-21 Wisconsin Alumni Research Foundation Methods of preventing oxidation, quenching singlet oxygen and inhibiting mold growth and novel compositions therefor
US5070104A (en) * 1989-02-17 1991-12-03 Wisconsin Alumni Research Foundation Methods of chelating metal and novel compositions therefor
US5045338A (en) * 1989-09-19 1991-09-03 Nabisco Brands, Inc. Secondary amide esters as low calorie fat mimetics
US5068119A (en) * 1990-09-28 1991-11-26 Nabisco Brands, Inc. Acid-hydrolyzable ester derivatives as low calorie fat mimetics
CA2097800C (en) * 1990-12-07 2003-04-29 Edward L. Wheeler Reduced calorie triglyceride mixtures
US5430066A (en) * 1992-04-29 1995-07-04 Wisconsin Alumni Research Foundation Methods for preventing weight loss, reduction in weight gain, and anorexia due to immune stimulation
US5428072A (en) * 1992-04-29 1995-06-27 Wisconsin Alumni Research Foundation Method of increasing the efficiency of feed conversion in animals
US5554646A (en) * 1992-04-29 1996-09-10 Wisconsin Alumni Research Foundation Method for reducing body fat in animals
JP3138358B2 (ja) * 1993-03-31 2001-02-26 雪印乳業株式会社 共役リノール酸の製造方法およびそれを含有させた食品
US5470839A (en) * 1993-04-22 1995-11-28 Clintec Nutrition Company Enteral diet and method for providing nutrition to a diabetic
US5814663A (en) * 1994-08-29 1998-09-29 Wisconsin Alumni Research Foundation Method for maintaining an existing level of body fat
US5760082C1 (en) * 1994-08-29 2001-03-06 Wisconsin Alumni Res Found Dietetic foods containing conjugated linoleic acids
ES2161969T3 (es) * 1995-11-14 2001-12-16 Unilever Nv Grasa comestible para untar.

Also Published As

Publication number Publication date
DE69719539D1 (de) 2003-04-10
EP0941088A1 (de) 1999-09-15
CA2267109C (en) 2006-08-22
WO1998019675A1 (en) 1998-05-14
AU5104198A (en) 1998-05-29
US5914346A (en) 1999-06-22
EP0941088B1 (de) 2003-03-05
JP2001503430A (ja) 2001-03-13
CA2267109A1 (en) 1998-05-14

Similar Documents

Publication Publication Date Title
DE69719539D1 (de) Verwendung von konjugiertes linolensäure zur steigerung der aktivität von natural killer-lymphozyten
DK0731699T3 (da) Fremgangsmåde til reduktion af legemsfedt i dyr ved indgivelse af konjugeret linolsyre
DE3787356D1 (de) Expression von höheren eukaryotischen genen in aspergillus.
DK0920309T3 (da) Konjugeret linolensyre til bevaring eller forøgelse af mineralindhold i knogler
ATE83263T1 (de) Regulatorregion fuer die expression von heterologen genen in hefe.
DE3781240D1 (de) Vorrichtung zur stimulation von gliedversteifungen.
DE3679366D1 (de) Vorrichtung zur abgabe von fluechtigen stoffen.
DK0918516T3 (da) Fremgangsmåde til forebyggelse af skeletale problemer hos fjerkræ
DK486587D0 (da) Gen, kodende for humane kolonistimulerende faktorer
DK0975359T3 (da) Anvendelse af forbindelser, der binder en cytoplasmisk dipeptidase til synergistisk virkning af immunreaktionen
DE59506057D1 (de) Kollagenzubereitung zur gesteuerten abgabe von wirkstoffen
DE3689055D1 (de) Vorrichtung zur Erzeugung höherer Oberwellen.
DE3781004D1 (de) Vorrichtung zur begrenzung von stromstoessen.
DE3777020D1 (de) Stopfen zur verwendung in bohrloechern.
ATE300295T1 (de) Verwendung von baclofen zur behandlung von alkoholismus
ATE70453T1 (de) Verwendung von interleukin-1-proteinen gegen arthritis.
DE58905973D1 (de) Einrichtung zur Abwehr von Vögeln.
DE69840637D1 (de) Zusammensetzungen zur steigerung der effizienz von impfstoffen unter verwendung von chemokinen
DE3673217D1 (de) Phenylalkyl-2,3-dihydrobenzofurane und analoga zur verwendung als antientzuendungsmittel.
DE69621146D1 (de) Verwendung von Galactanase in Tierfutter
DK1139782T3 (da) Fremgangsmåde til at forøge fedtfasthed og forbedre kødkvalitet hos dyr
NO890356L (no) Fremgangsmaate til aa utfoere vei- og markkonstruksjoner.
DE3750344D1 (de) Beschleuniger der Aktivität von Hydrolase.
FI901876A7 (fi) Epätäydelliset hepadnavirukset, rokotteita tuottavat solulinjat sekä m aksan sairauksien hoito
IT8120772A0 (it) Procedimento per modificare i prodotti in fibra animale strappando le scaglie.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties